Medlab Clinical Ltd (AU:MDC) has released an update.
Medlab Clinical Limited reported a significant decrease in revenues, down 97.7% to $13,747, alongside a reduced loss after tax of 58.9% to $(1,980,269) for the half-year ended December 31, 2023. The company did not pay, recommend, or declare any dividends during this period and noted a substantial drop in net tangible assets per security from 56.06 cents to (30.68) cents.
For further insights into AU:MDC stock, check out TipRanks’ Stock Analysis page.
